Biomaterial Database

Treatment of chronic otitis media with effusion: results of myringotomy. 1985

G A Gates, and C Wachtendorf, and E M Hearne, and G R Holt

UI	MeSH Term	Description	Entries
D010034	Otitis Media with Effusion	Inflammation of the middle ear with a clear pale yellow-colored transudate.	Middle Ear Effusion,Otitis Media, Secretory,Otitis Media, Serous,Ear Effusion, Middle,Ear Effusions, Middle,Effusion, Middle Ear,Effusions, Middle Ear,Middle Ear Effusions,Secretory Otitis Media,Serous Otitis Media
D011897	Random Allocation	A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.	Randomization,Allocation, Random
D012008	Recurrence	The return of a sign, symptom, or disease after a remission.	Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002908	Chronic Disease	Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).	Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D004322	Drainage	The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014432	Tympanic Membrane	An oval semitransparent membrane separating the external EAR CANAL from the tympanic cavity (EAR, MIDDLE). It contains three layers: the skin of the external ear canal; the core of radially and circularly arranged collagen fibers; and the MUCOSA of the middle ear.	Eardrum,Eardrums,Membrane, Tympanic,Membranes, Tympanic,Tympanic Membranes

Related Publications

G A Gates, and C Wachtendorf, and E M Hearne, and G R Holt

Diode laser myringotomy for chronic otitis media with effusion in adults.

January 2005, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,

G A Gates, and C Wachtendorf, and E M Hearne, and G R Holt

Myringotomy with and without tympanostomy tubes for chronic otitis media with effusion.

October 1989, Archives of otolaryngology--head & neck surgery,

G A Gates, and C Wachtendorf, and E M Hearne, and G R Holt

Predictors of Otitis Media with Effusion Recurrence Following Myringotomy.

December 2022, Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India,

G A Gates, and C Wachtendorf, and E M Hearne, and G R Holt

CO2 laser myringotomy in children with otitis media with effusion.

March 2006, The Journal of laryngology and otology,

G A Gates, and C Wachtendorf, and E M Hearne, and G R Holt

Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion.

April 1992, The Pediatric infectious disease journal,